TheraRadar
← Back
Data updated: Mar 29, 2026

IVAX SUB TEVA PHARMS

CardiovascularImmunologyDermatology
Generics

IVAX SUB TEVA PHARMS is a generic drug manufacturer focused on Cardiovascular, Immunology, Dermatology.

1963
Since
109
Drugs
-
Trials
891
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 38%
9 drugs
Immunology 21%
5 drugs
Dermatology 17%
4 drugs
Infectious Disease 17%
4 drugs
Neurology 8%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...